New Complications of Cholesterol-Lowering Drugs

Tens of millions of North Americans are taking cholesterol-lowering drugs (CLDs). For years, I’ve told readers I believe history will show this  to be a horrendous disaster with many unintended consequences.

Now, a study from the University of Texas Southwestern Medical Center finds that those using CLDs have a 27 percent greater risk of developing cataracts. Moreover, the longer CLDs are used, the greater the risk of cataracts. Another study at the University of Waterloo found that these drugs increase the risk of cataracts by 50 percent. The risk is even greater for those who have Type 2 diabetes.

Last year, the U.S. Food and Drug Administration issued a warning that CLDs could increase blood sugar, increase the risk of diabetes and cause memory loss. Yet big Pharma’s marketing has convinced doctors that CLDs are the answer to decrease the risk of heart attack.

For the last 15 years, following a coronary, I’ve said no to CLDs and relied on Medi-C Plus, a high concentration of vitamin C and lysine, to prevent another attack. To me, recent research warrants this approach to preventing and reversing atherosclerosis in coronary and other arteries.

Medi-C Plus is available at Scoop & Save Health Foods. But remember, I am not your doctor and you must seek advice from your own physician.

Gifford-Jones